Cargando…
New antithrombotic drugs: a revolution in stroke management
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Clinics Cardive Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721259/ https://www.ncbi.nlm.nih.gov/pubmed/22447472 |
| _version_ | 1782278054948634624 |
|---|---|
| author | Bryer, Alan |
| author_facet | Bryer, Alan |
| author_sort | Bryer, Alan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3721259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Clinics Cardive Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37212592013-08-07 New antithrombotic drugs: a revolution in stroke management Bryer, Alan Cardiovasc J Afr Editorial Clinics Cardive Publishing 2012-03 /pmc/articles/PMC3721259/ /pubmed/22447472 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Bryer, Alan New antithrombotic drugs: a revolution in stroke management |
| title | New antithrombotic drugs: a revolution in stroke management |
| title_full | New antithrombotic drugs: a revolution in stroke management |
| title_fullStr | New antithrombotic drugs: a revolution in stroke management |
| title_full_unstemmed | New antithrombotic drugs: a revolution in stroke management |
| title_short | New antithrombotic drugs: a revolution in stroke management |
| title_sort | new antithrombotic drugs: a revolution in stroke management |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721259/ https://www.ncbi.nlm.nih.gov/pubmed/22447472 |
| work_keys_str_mv | AT bryeralan newantithromboticdrugsarevolutioninstrokemanagement |